We found markedly lower levels of tumoural UBA6 in cancer patients with partial response (PR), or stable disease (SD) compared to that in cancer patients with progressive disease (PD) (Fig. 6c–e and Supplementary Fig. 8b, c). The gene discussed is UBA6; the disease is cancer.